Abstract
Approximately 20% of patients with severe acute respiratory syndrome (SARS) develop respiratory failure that requires admission to an intensive care unit (ICU). Old age, comorbidity, and elevated lactate dehydrogenase on hospital admission are associated with increased risk for ICU admission. ICU admission usually is late and occurs 8 to 10 days after symptom onset. Acute respiratory distress syndrome occurs in almost all admitted patients and most require mechanical ventilation. ICU admission is associated with significant morbidity, particularly an apparent increase in the incidence of barotrauma and nosocomial sepsis. Long-term mortality for patients admitted to the ICU ranges from 30% to 50%. Many procedures in ICUs pose a high risk for transmission of SARS coronavirus to health care workers. Contact and airborne infection isolation precautions, in addition to standard precautions, should be applied when caring for patients with SARS. Ensuring staff safety is important to maintain staff morale and delivery of adequate services.
Article PDF
Similar content being viewed by others
References and Recommended Reading
Fouchier RA, Kuiken T, Schutten M, et al.: Aetiology: Koch’s postulates fulfilled for SARS virus. Nature 2003, 423:240.
World Health Organization: Summary table of SARS cases by country, 1 November 2002–7 August 2003. http:// www.who.int/csr/sars/country/table2003_09_23/en/. Accessed January 8, 2004.
Cluster of severe acute respiratory syndrome cases among protected health-care workers--Toronto, Canada, April 2003. Morb Mortal Wkly Rep 2003, 52:433-436.
Fowler RA, Lapinsky SE, Hallett D, et al.: Critically ill patients with severe acute respiratory syndrome. JAMA 2003, 290:367–373. This is a detailed description of ICU patients with SARS.
Lew TW, Kwek TK, Tai D, et al.: Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003, 290:374–380. This is one of few studies providing information on ICU patients with SARS.
Booth CM, Matukas LM, Tomlinson GA, et al.: Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003, 289:2801–2809.
Lee N, Hui D, Wu A, et al.: A major outbreak of severe acute respiratory syndrome in Hong Kong. N Eng J Med 2003, 348:1986–1994.
Peiris JS, Chu CM, Cheng VC, et al.: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003, 361:1767–1772.
Choi KW, Chau TN, Tsang O, et al.: Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 2003, 139:715–723.
Peiris JS, Yuen KY, Osterhaus AD, Stohr K: The severe acute respiratory syndrome. N Engl J Med 2003, 349:2431–2441. This is an excellent review summarizing the current knowledge of SARS.
Gomersall CD, Joynt GM, Lam P, et al.: Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med 2004, 30:381–387. This is the only ICU study to focus on factors associated with outcome.
Bernard GR, Artigas A, Brigham KL, et al.: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818–824.
Tsui PT, Kwok ML, Yuen H, Lai ST: Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 2003, 9:1064–1069.
Nicholls JM, Poon LL, Lee KC, et al.: Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003, 361:1773–1778. This article contains some thought-provoking insights into the pathophysiology of SARS.
Ning Q, Brown D, Parodo J, et al.: Ribavirin inhibits viralinduced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 1998, 160:3487–3493.
Chu CM, Cheng VC, Hung IF, et al.: The role of lopinavir/ ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004, 59:252–256.
Hsu LY, Lee CC, Green JA, et al.: Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 2003, 9:713–717.
Chan KS, Lai ST, Chu CM: Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J 2003, 9:399–406.
Zhao Z, Zhang F, Xu M, et al.: Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003, 52:715–720.
So LK, Lau AC, Yam LY, et al.: Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003, 361:1615–1617.
Ho JC, Ooi GC, Mok TY, et al.: High dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 2003, 168:1449–1456.
Sung JJY, Wu A, Joynt GM, et al.: Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 2004, In press.
Thompson BT: Glucocorticoids and acute lung injury. Crit Care Med 2003, 31:S253-S257.
Meduri GU, Headley AS, Golden E, et al.: Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998, 280:159–165.
Brun-Buisson C, Brochard L: Corticosteroid therapy in acute respiratory distress syndrome: better late than never? JAMA 1998, 280:182–183.
Antonio GE, Wong KT, Chu WC, et al.: Imaging in severe acute respiratory syndrome (SARS). Clin Radiol 2003, 58:825–832.
Cordingley JJ, Keogh BF: The pulmonary physician in critical care: ventilatory management of ALI/ARDS. Thorax 2002, 8:729–734. This is a good review of ventilation of ARDS.
Gattinoni L, Chiumello D, Russo R: Reduced tidal volumes and lung protective ventilatory strategies: where do we go from here? Curr Opin Crit Care 2002, 8:45–50.
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. New Engl J Med 2000, 342:1301-1308. This is the first randomized controlled trial that showed ventilation with low tidal volumes reduces mortality.
Eichacker PQ, Gerstenberger EP, Banks SM, et al.: Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 2002, 166:1510–1514.
Ward NS: Effects of prone position ventilation in ARDS. An evidence-based review of the literature. Crit Care Clin 2002, 18:35–44.
Gattinoni L, Tognoni G, Pesenti A, et al.: Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001, 345:568–573.
Pelosi P, Gattinoni L: Acute respiratory distress syndrome of pulmonary and extra-pulmonary origin: fancy or reality? Intensive Care Med 2001, 27:457–460.
Gattinoni L, Pelosi P, Suter PM, et al.: Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am J Respir Crit Care Med 1998, 158:3–11.
Lim CM, Kim EK, Lee JS, et al.: Comparison of the response to the prone position between pulmonary and extrapulmonary acute respiratory distress syndrome. Intensive Care Med 2001, 27:477–485.
Dellinger RP, Zimmerman JL, Taylor RW, et al.: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998, 26:15–23.
Humphrey H, Hall J, Sznajder I, et al.: Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990, 97:1176–1180.
Mitchell JP, Schuller D, Calandrino FS, et al.: Improved outcome based on fluid management in critically ill patients requiring pulmonary catheter catheterization. Am Rev Respir Dis 1992, 145:990–998.
Joynt GM, Antonio GE, Lam P, et al.: Thin-section computed tomography abnormalities in patients with late adult respiratory distress syndrome (ARDS) caused by severe acute respiratory syndrome (SARS). Radiology 2004, 230:339–346.
Pittet D: Improving compliance with hand hygiene in hospitals. Infect Control Hosp Epidemiol 2000, 21:381–386.
Herridge MS, Cheung AM, Tansey CM, et al.: One-year outcomes in survivors of the ARDS. N Engl J Med 2003, 348:683–693.
Severe acute respiratory syndrome (SARS). Centers for Disease Control and Prevention, 2003. http://www.cdc.gov/ncidod/ sars. Accessed January 8, 2004. This contains detailed guidelines on infection control for SARS.
World Health Organization: Hospital infection control guidance for severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/infectioncontrol/en. Accessed April 11, 2003.
Gomersall CD, Joynt GM: Severe acute respiratory syndrome (SARS). http://www.aic.cuhk.hk/web8/sars.htm. Accessed January 8, 2004.
Li TS, Buckley TA, Yap FH, et al.: Severe acute respiratory syndrome (SARS): infection control. Lancet 2003, 361:1386.
Drosten C, Gunther S, Preiser W, et al.: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003, 348:1967–1976.
Tomlinson B, Cockram C: SARS: experience at Prince of Wales Hospital, Hong Kong. Lancet 2003, 361:1486–1487.
Hong Kong Department of Health Report. Main findings of an investigation into the outbreak of severe acute respiratory syndrome at Amoy Gardens. http://www.info.gov.hk/dh/ ap.htm. Accessed April 19, 2003.
Garner JS, Hospital Infection Control Practices Advisory Committee: Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996, 17:53–80, and Am J Infect Control 1996, 24:24–52.
Respiratory Protection Program. US Department of Labor. Occupational Safety and Health Administration. http://www.osha.gov/SLTC/etools/respiratory. Accessed January 8, 2004.
Hospital infection control guidance for severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/infectioncontrol/ en. Accessed April 11, 2003.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Joynt, G.M., Yap, H.Y. SARS in the intensive care unit. Curr Infect Dis Rep 6, 228–233 (2004). https://doi.org/10.1007/s11908-004-0013-6
Issue Date:
DOI: https://doi.org/10.1007/s11908-004-0013-6